TachoSil
- Business
Takeda Completes Sale of TachoSil® to Corza Health
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch…
Read More » -
Takeda to Divest TachoSil® to Corza Health for €350 Million
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest its…
Read More »